Literature DB >> 16917730

A review of the psychosocial effects of false-positive results on parents and current communication practices in newborn screening.

J Hewlett1, S E Waisbren.   

Abstract

As more states adopt expanded newborn screening for metabolic disorders, the overall number of false positives increases. False-positive screening results have been associated with increased anxiety and stress in parents of infants who require follow-up testing, even after the infant's good health is confirmed. This article reviews the literature on the negative impact of false-positive newborn screening results on parents, along with a review of current communication practices for follow-up screening. The results of this review suggest that parental stress and anxiety can be reduced with improved education and communication to parents, specifically at the time of follow-up screening. Communication strategies with sample materials are proposed.

Entities:  

Mesh:

Year:  2006        PMID: 16917730     DOI: 10.1007/s10545-006-0381-1

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  25 in total

1.  Serving the family from birth to the medical home. Newborn screening: a blueprint for the future - a call for a national agenda on state newborn screening programs

Authors: 
Journal:  Pediatrics       Date:  2000-08       Impact factor: 7.124

2.  Informing parents about newborn screening.

Authors:  Alex R Kemper; Kathryn E Fant; Sarah J Clark
Journal:  Public Health Nurs       Date:  2005 Jul-Aug       Impact factor: 1.462

3.  Psychological impact of false-positive results when screening for cystic fibrosis.

Authors:  A Tluczek; E H Mischler; B Bowers; N M Peterson; M E Morris; P M Farrell; W T Bruns; H Colby; C McCarthy; N Fost
Journal:  Pediatr Pulmonol Suppl       Date:  1991

4.  The false-positive in universal newborn hearing screening.

Authors:  C J Clemens; S A Davis; A R Bailey
Journal:  Pediatrics       Date:  2000-07       Impact factor: 7.124

5.  Psychological reactions in 102 families with a newborn who has a falsely positive screening test for congenital hypothyroidism.

Authors:  G Bodegård; K Fyrö; A Larsson
Journal:  Acta Paediatr Scand Suppl       Date:  1983

6.  Cystic fibrosis newborn screening: impact of early screening results on parenting stress.

Authors:  M A Baroni; Y E Anderson; E Mischler
Journal:  Pediatr Nurs       Date:  1997 Mar-Apr

Review 7.  A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism.

Authors:  M J Thomason; J Lord; M D Bain; R A Chalmers; P Littlejohns; G M Addison; A H Wilcox; C A Seymour
Journal:  J Public Health Med       Date:  1998-09

8.  Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.

Authors:  Andreas Schulze; Martin Lindner; Dirk Kohlmüller; Katharina Olgemöller; Ertan Mayatepek; Georg F Hoffmann
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

9.  Examination of the communication practices between state newborn screening programs and the medical home.

Authors:  Sunnah Kim; Michele A Lloyd-Puryear; Thomas F Tonniges
Journal:  Pediatrics       Date:  2003-02       Impact factor: 7.124

Review 10.  Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review.

Authors:  J M Green; J Hewison; H L Bekker; L D Bryant; H S Cuckle
Journal:  Health Technol Assess       Date:  2004-08       Impact factor: 4.014

View more
  38 in total

1.  Improving communication between doctors and parents after newborn screening.

Authors:  Michael H Farrell; Stephanie A Christopher; Audrey Tluczek; Karen Kennedy-Parker; Alison La Pean; Kerry Eskra; Jenelle Collins; Gary Hoffman; Julie Panepinto; Philip M Farrell
Journal:  WMJ       Date:  2011-10

2.  Newborn screening education on the internet: a content analysis of North American newborn screening program websites.

Authors:  Makda H Araia; Beth K Potter
Journal:  J Community Genet       Date:  2011-04-15

3.  Expanded newborn screening: reducing harm, assessing benefit.

Authors:  Bridget Wilcken
Journal:  J Inherit Metab Dis       Date:  2010-05-04       Impact factor: 4.982

4.  Qualitative Research on Expanded Prenatal and Newborn Screening: Robust but Marginalized.

Authors:  Rachel Grob
Journal:  Hastings Cent Rep       Date:  2019-05       Impact factor: 2.683

5.  Application of a second-tier newborn screening assay for c5 isoforms.

Authors:  T Cloppenborg; N Janzen; Hj Wagner; U Steuerwald; M Peter; Am Das
Journal:  JIMD Rep       Date:  2013-11-06

6.  Supporting family adaptation to presymptomatic and "untreatable" conditions in an era of expanded newborn screening.

Authors:  Donald B Bailey; F Daniel Armstrong; Alex R Kemper; Debra Skinner; Steven F Warren
Journal:  J Pediatr Psychol       Date:  2008-03-30

Review 7.  Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening.

Authors:  Yvonne Bombard; Fiona A Miller; Robin Z Hayeems; Denise Avard; Bartha M Knoppers
Journal:  Eur J Hum Genet       Date:  2010-03-03       Impact factor: 4.246

8.  Psychosocial Distress and Knowledge Deficiencies in Parents of Children in Ireland Who Carry an Altered Cystic Fibrosis Gene.

Authors:  S J Quigley; B Linnane; S Connellan; A Ward; P Ryan
Journal:  J Genet Couns       Date:  2017-09-26       Impact factor: 2.537

9.  Parents' experience with positive newborn screening results for cystic fibrosis.

Authors:  Inken Brockow; Uta Nennstiel
Journal:  Eur J Pediatr       Date:  2019-03-09       Impact factor: 3.183

10.  Psychosocial impact on mothers receiving expanded newborn screening results.

Authors:  Kathleen O'Connor; Tara Jukes; Sharan Goobie; Jennifer DiRaimo; Greg Moran; Beth Katherine Potter; Pranesh Chakraborty; Charles Anthony Rupar; Srinitya Gannavarapu; Chitra Prasad
Journal:  Eur J Hum Genet       Date:  2018-01-29       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.